The expanded facility will add additional capacities and capabilities to support Pfizer’s growing gene therapy unit.
The Sanford-based plant currently manufactures therapies for hemophilia B and Duchenne muscular dystrophy, among other gene therapies.
The expanded facility will create about 300 jobs.
More articles on pharmacy:
FDA approves AbbVie’s $59K rheumatoid arthritis drug
Teva launches generic version of EpiPen for kids
American Regent boosted price of essential hospital product by 1,300%
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.